Literature DB >> 18410980

Safety of dermatologic drugs used in pregnant patients with psoriasis and other inflammatory skin diseases.

Joseph Lam1, Janine E Polifka, Magdalene A Dohil.   

Abstract

In patients with psoriasis, there is an increased availability of drugs for treatment. However, there are important questions about drug safety for mothers with psoriasis and their fetuses. Currently, there are limited safety data for many of the medications used. In this article, we review current pregnancy risk information for medications commonly used in the treatment of psoriasis. In addition, a list of teratology information resources is included to help practicing clinicians find up-to-date information regarding the safety of the medications they prescribe.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18410980     DOI： 10.1016/j.jaad.2008.03.018

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


  10 in total

1.  Drug prescribing before and during pregnancy in south west France: a retrolective study.

Authors:  Sophie Crespin; Robert Bourrel; Caroline Hurault-Delarue; Maryse Lapeyre-Mestre; Jean-Louis Montastruc; Christine Damase-Michel
Journal:  Drug Saf       Date:  2011-07-01       Impact factor: 5.606

2.  First-trimester nonsystemic corticosteroid use and the risk of oral clefts in Norway.

Authors:  Hildur Skuladottir; Allen Wilcox; Robert McConnaughey; Hallvard Vindenes; Rolv T Lie
Journal:  Ann Epidemiol       Date:  2014-07-08       Impact factor: 3.797

Review 3.  The Psoriasis Decision Tree.

Authors:  George Monks; Ryan Rivera-Oyola; Mark Lebwohl
Journal:  J Clin Aesthet Dermatol       Date:  2021-04-01

Review 4.  The impact of gender and sex in psoriasis: What to be aware of when treating women with psoriasis.

Authors:  Carole Guillet; Corsin Seeli; Meienberger Nina; Lara Valeska Maul; Julia-Tatjana Maul
Journal:  Int J Womens Dermatol       Date:  2022-04-13

Review 5.  Treatment of psoriasis and psoriatic arthritis during pregnancy and breastfeeding.

Authors:  Patricia Shu Kurizky; Clarissa de Castro Ferreira; Lucas Souza Carmo Nogueira; Licia Maria Henrique da Mota
Journal:  An Bras Dermatol       Date:  2015 May-Jun       Impact factor: 1.896

Review 6.  Mast cell-mediated and associated disorders in pregnancy: a risky game with an uncertain outcome?

Authors:  Katja Woidacki; Ana Claudia Zenclussen; Frank Siebenhaar
Journal:  Front Immunol       Date:  2014-05-19       Impact factor: 7.561

Review 7.  Managing Patients With Psoriasis in the Busy Clinic: Practical Tips for Health Care Practitioners.

Authors:  April W Armstrong; Lakshi Aldredge; Paul S Yamauchi
Journal:  J Cutan Med Surg       Date:  2015-12-28       Impact factor: 2.092

Review 8.  Phototherapy in Scleroderma.

Authors:  John Hassani; Steven R Feldman
Journal:  Dermatol Ther (Heidelb)       Date:  2016-08-12

Review 9.  Topical Therapies in Psoriasis.

Authors:  R Torsekar; Manjyot M Gautam
Journal:  Indian Dermatol Online J       Date:  2017 Jul-Aug

Review 10.  Psoriasis in pregnancy: challenges and solutions.

Authors:  Gino Antonio Vena; Nicoletta Cassano; Gilberto Bellia; Delia Colombo
Journal:  Psoriasis (Auckl)       Date:  2015-05-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.